Page last updated: 2024-12-07

18-oxocortisol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

## 18-oxocortisol: An Important Biomarker in Research

18-oxocortisol is a **steroid hormone** that is a **metabolite of cortisol**. It is produced in the body by the enzyme **11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2)**.

Here's why it is important for research:

**1. Diagnostic tool for specific conditions:**

* **Congenital adrenal hyperplasia (CAH):** 18-oxocortisol levels are **elevated** in individuals with certain types of CAH, specifically **11β-hydroxylase deficiency**. This is because the enzyme responsible for cortisol production is deficient, causing a build-up of precursors, including 18-oxocortisol.
* **Cushing's syndrome:** While not as specific as in CAH, 18-oxocortisol levels can be **elevated** in some cases of Cushing's syndrome, a condition characterized by excess cortisol production. However, other tests like 24-hour urinary free cortisol are more commonly used for diagnosis.
* **Monitoring treatment:** 18-oxocortisol levels can be used to **monitor the effectiveness of treatment** for conditions like CAH.

**2. Understanding cortisol metabolism and its impact on health:**

* **11β-HSD2 activity:** Measuring 18-oxocortisol can help researchers understand the activity of **11β-HSD2**, which is crucial for maintaining cortisol levels and regulating its effects on different tissues.
* **Cortisol regulation:** 18-oxocortisol is also implicated in the **regulation of cortisol levels** in the body, which can have implications for various physiological processes, including stress response, blood sugar control, and inflammation.

**3. Research into other areas:**

* **Anti-inflammatory effects:** Some studies suggest that 18-oxocortisol might have **anti-inflammatory effects**, potentially due to its ability to suppress the production of pro-inflammatory cytokines.
* **Cardiovascular health:** There is also research exploring the link between 18-oxocortisol and **cardiovascular health**. Some studies suggest that elevated 18-oxocortisol levels might be associated with increased risk of cardiovascular disease.

**In summary, 18-oxocortisol is a crucial biomarker in research, providing insights into cortisol metabolism, diagnosis of specific conditions, and potentially contributing to the understanding of its role in various physiological processes and health outcomes.**

**It's important to note that further research is needed to fully elucidate the role of 18-oxocortisol in human health.**

18-oxocortisol: biosynthesized by aldosterone-producing adrenal tissue; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

18-oxocortisol : A steroid aldehyde that is cortisol carrying a formyl group at position 18. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID44263344
CHEBI ID89213
SCHEMBL ID144491
MeSH IDM0114932

Synonyms (5)

Synonym
18-oxocortisol
LMST02030194
SCHEMBL144491
CHEBI:89213
Q27161399

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"The hypertensogenic effect of 18-oxocortisol, an aldosterone analogue possessing both mineralocorticoid and glucocorticoid properties, was studied at the same dosage but under different experimental conditions in two experiments."( Hypertensive potency of 18-oxocortisol in the rat.
Gomez-Sanchez, CE; Hall, CE, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (53)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (30.19)18.7374
1990's15 (28.30)18.2507
2000's7 (13.21)29.6817
2010's10 (18.87)24.3611
2020's5 (9.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.57%)5.53%
Reviews6 (10.71%)6.00%
Case Studies1 (1.79%)4.05%
Observational0 (0.00%)0.25%
Other47 (83.93%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]